Long/short equity, biotech, healthcare, small-cap

Salix Pharmaceuticals: Why You Shouldn't Be Dumping This Stock

Salix Pharmaceuticals (NASDAQ:SLXP) is a specialist pharmacy company that develops, acquires and commercializes prescription drugs, and medical devices used in the treatment of various forms of GI diseases. Gastrointestinal, or GI, disease is one of the most widespread diseases in the U.S., and it results in substantial morbidity, mortality, and healthcare costs. The most prevalent form of these diseases are non-food-borne gastroenteritis, GI infections, food borne illness, gastro esophageal reflux disease, gallbladder disease, irritable bowel syndrome, and opioid-induced constipation.

Salix offers tablets such as Xifaxan, Moviprep, Osmoprep, Apriso, Giazo, Colazal, Fulyzaq, Solesta, Deflux, etc.

Currently Salix is gaining traction with its drugs -- Relistor and Xifaxan, which are awaiting FDA approval. However due to the uncertainty surrounding the...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
PRO Top long ideas returned 21.7% in 2016**
"As a PRO member, we get uniquely valuable perspective that go beyond our quantiative analysis... We rely on PRO to get beyond the numbers quickly and add much needed perspective. It keeps me ahead of the next big thing. - Mark Choate, Malaga Cove Capital"
Mark Choate, Malaga Cove Capital
"Contributors (writers and commentators), often have a long history in the secuirities they opine on and some are clearly well positioned industry participants with detailed industry views that can help provide color on where the skeletons are buried in a particular secuirity and/or industry."
Jim Roumell, Roumell Asset Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details